Sees FY25 adjusted EBITDA $30M-$32M vs. $14.4M in FY24. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on LFMD: LifeMD options imply 11.7% move in share price post-earnings Options Volatility and Implied Earnings Moves Today, March 10, 2025 Lifemd, Inc. (LFMD) Q4 Earnings Cheat Sheet LifeMD announces integration with LillyDirect pharmacy provider LifeMD announces expansion into behavioral health market Disclaimer & DisclosureReport an Issue
